1. |
Stengel B, Metzger M, Froissart M, et al. Epidemiology and prognostic significance of chronic kidney disease in the elderly—the three-city prospective cohort study. Nephrol Dial Transplant, 2011, 26(10): 3286-3295.
|
2. |
Formiga F, Ferrer A, Cruzado JM, et al. Geriatric assessment and chronic kidney disease in the oldest old: the Octabaix study. EurJ Intern Med, 2012, 23(6): 534-538.
|
3. |
Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet, 2019, 393(10191): 2636-2646.
|
4. |
Dent E, Morley JE, Cruz-Jentoft AJ, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging, 2018, 22(10): 1148-1161.
|
5. |
Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr, 1997, 127(5 Suppl): 990S-991S.
|
6. |
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing, 2010, 39(4): 412-423.
|
7. |
Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for sarcopenia. J Am Med Dir Assoc, 2014, 15(2): 95-101.
|
8. |
Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle, 2016, 7(5): 512-514.
|
9. |
Chen LK, Lee WJ, Peng LN, et al. Recent advances in sarcopenia research in Asia: 2016 update from the Asian Working Group for Sarcopenia. J Am Med Dir Assoc, 2016, 17(8): 767.e1-767.e7677.
|
10. |
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing, 2019, 48(1): 16-31.
|
11. |
Chen LK, Woo J, Assantachai P, et al. Asian Working Group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc, 2020, 21(3): 300.e2-307.e2.
|
12. |
Mitchell WK, Williams J, Atherton P, et al. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol, 2012, 3: 260.
|
13. |
Gielen E, O'Neill TW, Pye SR, et al. Endocrine determinants of incident sarcopenia in middle-aged and elderly European men. J Cachexia Sarcopenia Muscle, 2015, 6(3): 242-252.
|
14. |
Yu R, Wong M, Leung J, et al. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. Geriatr Gerontol Int, 2014, 14(Suppl 1): 15-28.
|
15. |
Dodds RM, Granic A, Davies K, et al. Prevalence and incidence of sarcopenia in the very old: findings from the Newcastle 85+ Study. J Cachexia Sarcopenia Muscle, 2017, 8(2): 229-237.
|
16. |
Moon SJ, Kim TH, Yoon SY, et al. Relationship between stage of chronic kidney disease and sarcopenia in Korean aged 40 years and older using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2, 3, and V-1, 2), 2008-2011. PLoS One, 2015, 10(6): e0130740.
|
17. |
Kim JK, Choi SR, Choi MJ, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr, 2014, 33(1): 64-68.
|
18. |
Lamarca F, Carrero JJ, Rodrigues JC, et al. Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria. J Nutr Health Aging, 2014, 18(7): 710-717.
|
19. |
Chang YT, Wu HL, Guo HR, et al. Handgrip strength is an independent predictor of renal outcomes in patients with chronic kidney diseases. Nephrol Dial Transplant, 2011, 26(11): 3588-3595.
|
20. |
Roshanravan B, Robinson-Cohen C, Patel KV, et al. Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol, 2013, 24(5): 822-830.
|
21. |
Pereira RA, Cordeiro AC, Avesani CM, et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant, 2015, 30(10): 1718-1725.
|
22. |
Hanatani S, Izumiya Y, Onoue Y, et al. Non-invasive testing for sarcopenia predicts future cardiovascular events in patients with chronic kidney disease. Int J Cardiol, 2018, 268: 216-221.
|
23. |
Koufaki P, Greenwood SA, Macdougall IC, et al. Exercise therapy in individuals with chronic kidney disease: a systematic review and synthesis of the research evidence. Annu Rev Nurs Res, 2013, 31: 235-275.
|
24. |
Painter P, Roshanravan B. The association of physical activity and physical function with clinical outcomes in adults with chronic kidney disease. Curr Opin Nephrol Hypertens, 2013, 22(6): 615-623.
|
25. |
Beddhu S, Baird BC, Zitterkoph J, et al. Physical activity and mortality in chronic kidney disease (NHANES Ⅲ). Clin J Am Soc Nephrol, 2009, 4(12): 1901-1906.
|
26. |
Ricardo AC, Madero M, Yang W, et al. Adherence to a healthy lifestyle and all-cause mortality in CKD. Clin J Am Soc Nephrol, 2013, 8(4): 602-609.
|
27. |
Chen IR, Wang SM, Liang CC, et al. Association of walking with survival and RRT among patients with CKD stages 3-5. Clin J Am Soc Nephrol, 2014, 9(7): 1183-1189.
|
28. |
Vlietstra L, Hendrickx W, Waters DL. Exercise interventions in healthy older adults with sarcopenia: a systematic review and meta-analysis. Australas J Ageing, 2018, 37(3): 169-183.
|
29. |
Hirai K, Ookawara S, Morishita Y. Sarcopenia and physical inactivity in patients with chronic kidney disease. Nephrourol Mon, 2016, 8(3): e37443.
|
30. |
Heiwe S, Jacobson SH. Exercise training in adults with CKD:a systematic review and meta-analysis. Am J Kidney Dis, 2014, 64(3): 383-393.
|
31. |
American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription, tenth edition. (2018-01-22)[2020-06-05]. https://www.doc88.com/p-3117449074960.html..
|
32. |
Andrassy KM. Comments on “KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease”. Kidney Int, 2013, 84(3): 622-623.
|
33. |
Heiwe S, Jacobson SH. Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev, 2011(10): CD003236.
|